TLTTheralase Technologies Inc.
0.1850CAD0.00%Mkt Cap: 37.16M $P/E:

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United…

Key Statistics

Company
Market Cap37.16M $
Enterprise Value40.50M $
Revenue (TTM)624.78K $
Gross Profit369.32K $
Net Income (TTM)-3.00M $
Revenue/Share0.0022 USD
Last Price0.1850 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees
CountryCA
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-19.00
PEG
EV/EBITDA-15.65
EV/Revenue64.81
P/S65.48
P/B27.14
EPS (TTM)-0.01
EPS (Forward)-0.01
52W Range
0.150013% of range0.4100
52W High0.4100 CAD
52W Low0.1500 CAD
Profitability
Gross Margin62.11%
Oper. Margin-776.89%
EBITDA Margin0.00%
Profit Margin-504.71%
ROE-231.79%
ROA-117.92%
Growth
Revenue Growth45.40%
Earnings Growth
Cash Flow & Leverage
Operating CF-2.39M $
CapEx (TTM)35.64K $
FCF Margin-225.13%
FCF Yield-3.79%
Net Debt-416.83K $
Net Debt/EBITDA0.16
Balance Sheet
Debt/Equity0.26
Current Ratio1.37
Quick Ratio1.01
Book Value/Sh0.0070 CAD
Cash/Share0.0030 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)0.7000 CAD
Upside (mean)+278.4%
Target Range0.7000 CAD0.7000 CAD
# Analysts1
Ownership
Shares Out.275.82M
Float276.45M
Insiders8.40%
Institutions0.00%
Short Interest
Short Ratio0.8d
Short % Out.0.02%
Shares Short128.28K
Short (prev mo.)20.30K
Technical
SMA 500.2452 (-24.6%)
SMA 2000.2460 (-24.8%)
Beta0.59
S&P 52W Chg18.16%
Avg Vol (30d)234.10K
Avg Vol (10d)649.19K
Technical Indicators
RSI (14)28.5
MACD-0.0183
MACD Signal-0.0082
MACD Hist.-0.0101
BB Upper0.3175 CAD
BB Middle0.2440 CAD
BB Lower0.1705 CAD
BB Width60.27%
ATR (14)0.0148 CAD
Vol Ratio (20d)1.15x